Collaboration Details

Print  Close


Title of Collaborative Activity:

Policies and Regulatory Pathways to FDA Licensure

Description of Collaborative Activity:

The purpose of this meeting was to understand the policies that advance radiation countermeasure agents and biodosimetry devices towards eventual FDA approval. Manuscript preparation is ongoing with input from all agencies, with anticipated submission to Radiation Research

Type of Collaborative Activity:

Meeting/ Workshop

Year the Collaborative Activity Originated:

2018

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

FDA